Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Remifentanil for controlled hypotension during rhinoplasty
IRCT20190410043231N1Phase 2Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Apr 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of dexmedetomidine and remifentanil in None (2 arms), sponsored by Arak University of Medical Sciences. Primary endpoint: Quality of controlled hypotension. Started Apr 2019; status: completed.
02
Drugs
dexmedetomidineremifentanil
Beyond the preview
Go deeper on IRCT20190410043231N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190410043231N1.